Chinese (SSE) Life Sciences Industry Analysis
- 7D-3.4%
- 3M-23.3%
- 1Y-19.9%
- YTD-3.0%
Over the last 7 days, the Life Sciences industry has dropped 4.5%, driven by a pullback from WuXi AppTec of 2.1%. However, the industry is down 25% over the past year.
Industry Valuation and Performance
Has the Chinese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Wed, 26 Jan 2022 | CN„670.6b | CN„57.5b | CN„12.3b | 71.4x |
| Fri, 24 Dec 2021 | CN„709.7b | CN„56.9b | CN„12.1b | 81.1x |
| Sun, 21 Nov 2021 | CN„831.5b | CN„56.9b | CN„12.1b | 91.7x |
| Tue, 19 Oct 2021 | CN„906.8b | CN„53.4b | CN„11.5b | 108.6x |
| Thu, 16 Sep 2021 | CN„958.2b | CN„55.1b | CN„12.7b | 98.6x |
| Sat, 14 Aug 2021 | CN„908.4b | CN„53.4b | CN„11.5b | 104.2x |
| Wed, 09 Jun 2021 | CN„856.8b | CN„46.5b | CN„10.6b | 93.7x |
| Tue, 02 Mar 2021 | CN„674.5b | CN„39.5b | CN„7.8b | 76.7x |
| Fri, 04 Dec 2020 | CN„508.3b | CN„36.6b | CN„6.7b | 79.5x |
| Mon, 07 Sep 2020 | CN„542.7b | CN„34.2b | CN„6.3b | 97.7x |
| Sun, 31 May 2020 | CN„387.2b | CN„32.6b | CN„4.5b | 90.3x |
| Wed, 04 Mar 2020 | CN„328.6b | CN„32.0b | CN„4.4b | 81.2x |
| Sat, 07 Dec 2019 | CN„266.5b | CN„30.0b | CN„4.1b | 68.2x |
| Tue, 10 Sep 2019 | CN„247.0b | CN„27.6b | CN„3.8b | 72.6x |
| Mon, 03 Jun 2019 | CN„180.2b | CN„26.0b | CN„3.9b | 63.8x |
| Thu, 07 Mar 2019 | CN„183.7b | CN„24.6b | CN„3.8b | 59.6x |
38.7x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 79.5x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Life Sciences industry have grown 49% per year over the last three years, and revenues for these companies have grown 33% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Chinese Life Sciences industry?
| Clinical Research and Equipment | -3.43% | |
Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry, which is trading close to its 3-year average PE ratio of 79.5x. However analysts are expecting annual earnings growth of 26%, which is lower than the prior year's growth of 61% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 26% over the next 5 years. However this is lower than its past earnings growth rate of 61% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603127 Joinn Laboratories (China)Ltd | CN„99.54 | 1.0% +CN„388.9m | -4.4% | PE90.5x |